EARNEST Partners’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-33
| Closed | -$3K | – | 1193 |
|
|
2021
Q1 | $3K | Hold |
33
| – | – | ﹤0.01% | 998 |
|
|
2020
Q4 | $3K | Hold |
33
| – | – | ﹤0.01% | 983 |
|
|
2020
Q3 | $1K | Hold |
33
| – | – | ﹤0.01% | 1148 |
|
|
2020
Q2 | $1K | Hold |
33
| – | – | ﹤0.01% | 1133 |
|
|
2020
Q1 | $1K | Hold |
33
| – | – | ﹤0.01% | 1094 |
|
|
2019
Q4 | $2K | Hold |
33
| – | – | ﹤0.01% | 1057 |
|
|
2019
Q3 | $2K | Hold |
33
| – | – | ﹤0.01% | 1042 |
|
|
2019
Q2 | $3K | Sell |
33
-43,028
| -100% | -$3.03M | ﹤0.01% | 960 |
|
|
2019
Q1 | $2.88M | Sell |
43,061
-2,324
| -5% | -$176K | 0.03% | 201 |
|
|
2018
Q4 | $3.38M | Sell |
45,385
-730,678
| -94% | -$60.3M | 0.04% | 194 |
|
|
2018
Q3 | $71.4M | Sell |
776,063
-6,318
| -0.8% | -$602K | 0.64% | 66 |
|
|
2018
Q2 | $77M | Buy |
782,381
+1,310
| +0.2% | +$147K | 0.72% | 57 |
|
|
2018
Q1 | $87M | Buy |
781,071
+15,814
| +2% | +$1.77M | 0.82% | 42 |
|
|
2017
Q4 | $78.7M | Sell |
765,257
-6,539
| -0.8% | -$651K | 0.75% | 50 |
|
|
2017
Q3 | $72.7M | Buy |
771,796
+8,446
| +1% | +$667K | 0.72% | 50 |
|
|
2017
Q2 | $59.5M | Buy |
763,350
+11,474
| +2% | +$862K | 0.62% | 67 |
|
|
2017
Q1 | $60.2M | Sell |
751,876
-13,513
| -2% | -$1.07M | 0.64% | 62 |
|
|
2016
Q4 | $60.3M | Sell |
765,389
-60,337
| -7% | -$4.69M | 0.66% | 61 |
|
|
2016
Q3 | $64.4M | Sell |
825,726
-42,795
| -5% | -$3.1M | 0.68% | 52 |
|
|
2016
Q2 | $59.7M | Sell |
868,521
-898,232
| -51% | -$62M | 0.65% | 53 |
|
|
2016
Q1 | $126M | Sell |
1,766,753
-226,604
| -11% | -$14.2M | 1.32% | 13 |
|
|
2015
Q4 | $124M | Sell |
1,993,357
-72,155
| -3% | -$4.4M | 1.26% | 16 |
|
|
2015
Q3 | $117M | Sell |
2,065,512
-101,053
| -5% | -$5.35M | 1.15% | 17 |
|
|
2015
Q2 | $116M | Buy |
2,166,565
+8,765
| +0.4% | +$426K | 1.02% | 24 |
|
|
2015
Q1 | $102M | Sell |
2,157,800
-220,397
| -9% | -$9.76M | 0.88% | 34 |
|
|
2014
Q4 | $103M | Sell |
2,378,197
-18,241
| -0.8% | -$745K | 0.84% | 39 |
|
|
2014
Q3 | $82.4M | Buy |
2,396,438
+57,324
| +2% | +$2.02M | 0.69% | 48 |
|
|
2014
Q2 | $85.7M | Sell |
2,339,114
-29,638
| -1% | -$1.01M | 0.68% | 52 |
|
|
2014
Q1 | $79.9M | Sell |
2,368,752
-143,843
| -6% | -$4.75M | 0.64% | 52 |
|
|
2013
Q4 | $85.2M | Buy |
+2,512,595
| New | +$87M | 0.68% | 52 |
|
EARNEST Partners's CMD Position: Q2 2021 in Review
EARNEST Partners sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 33 shares — an estimated $3K sold.
EARNEST Partners first reported a position in CMD in Q4 2013 and held it in 30 quarters. The position peaked at $126M in Q1 2016. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- EARNEST Partners reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- EARNEST Partners sold 33 Cantel Medical Corporation shares in Q2 2021, an estimated $3K.
- EARNEST Partners first reported a position in Cantel Medical Corporation in Q4 2013 and held it in 30 quarters.
- EARNEST Partners's Cantel Medical Corporation position peaked at $126M in Q1 2016.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on EARNEST Partners's 13F filing for Q2 2021, filed 16 Aug 2021.